Table of Content


Tables
Charts
Abbott Laboratories - Key Company Facts
Abbott Laboratories - Company Description
Abbott Laboratories - Top Executives
Abbott Laboratories- Top Executives Biographies
Abbott Laboratories- Head Office & Locations
Head Office - Country
Key Subsidiaries
Abbott Laboratories - Products and Services
Products
Abbott Laboratories - Historic Events
Abbott Laboratories – Company’s Management Discussion
Abbott Laboratories – Company’s Mission and Vision
Mission
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - Business Description
Established Pharmaceuticals
Medical Devices
Nutrition
Diagnostics
Abbott Laboratories - ESG Spotlight
Environment
Social
Corporate Governance
Abbott Laboratories - SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Abbott Laboratories – PESTLE Analysis
Overview
Political Factors
Economic Factors
Social Factors
Technological Factors
Legal Factors
Environmental Factors
Abbott Laboratories - Financial Deep Dive
Share Price Trend - Dec-2022 to Nov-2023 (Average Share Closing Price)
Profit and Loss Statement
Summary of Profit and Loss Statement
Balance Sheet
Summary of Balance Sheet
Cash Flow Statement
Summary of Cash Flow Statement
Key Financial Ratio Analysis
Abbott Laboratories - Ratio Charts
Activity Ratio Charts
Growth Ratios Charts
Leverage Ratio Charts
Liquidity Ratio Charts
Profitability Ratio Charts
Competing Players
Snapshot of Competing Players
Boston Scientific Corporation
Key Company Facts
Company Description
Snapshot of Competing Players
Johnson & Johnson
Key Company Facts
Company Description
Snapshot of Competing Players
Sanofi
Key Company Facts
Company Description
Snapshot of Competing Players
Stryker Corporation
Key Company Facts
Company Description
Abbott Laboratories - Key Deals
23-Nov-2023 - Abbott to upgrade 75 primary health centres across india, providing quality, accessible care to 2.5 million people
24-Jun-2023 - The american diabetes association and abbott collaborate on first-of-its-kind therapeutic nutrition program for people with diabetes

31-May-2023 - Abbott, real madrid and the real madrid foundation band together to ’beat malnutrition’ globally through new campaign
27-Apr-2023 - Abbott completes acquisition of cardiovascular systems, inc.
20-Apr-2023 - Abbott and new global consortium partnership address viral outbreaks caused by climate change
13-Dec-2022 - Abbott and the brain injury association of america launch concussion awareness now coalition; team up with rebel wilson to raise awareness on seriousness of concussions
12-Oct-2022 - Abbott and the home edit redesign the medicine cabinet to help people prepare for the upcoming virus season
04-Aug-2022 - Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals
22-Jun-2022 - Easterseals and the abbott fund join together to advance education and health equity
27-Apr-2022 - Abbott, camdiab and ypsomed unveil new automated insulin delivery partnership for people with diabetes
Abbott Laboratories - In the News
05-Jul-2023 - Abbott receives fda approval for world’s first dual chamber leadless pacemaker
03-Jul-2023 - Abbott receives fda clearance for first commercially available lab-based blood test to help evaluate concussion
22-Jun-2023 - Abbott’s freestyle libre? 2 receives national reimbursement in france for all people with diabetes who use insulin?
03-Jun-2023 - U.S. Fda clears abbott’s freestyle libre? 2 and freestyle libre? 3 sensors for integration with automated insulin delivery systems
19-May-2023 - Abbott receives fda approval for tactiflex? ablation catheter for treatment of abnormal heart rhythm
18-May-2023 - Abbott receives fda clearance for assert-iq? insertable cardiac monitor to help doctors monitor people’s heart rhythms long-term
16-May-2023 - Abbott receives fda approval for its spinal cord stimulation systems to treat chronic back pain in people who have limited surgical options

30-Mar-2023 - Abbott receives fda approval for epic? max tissue valve to treat aortic valve disease
02-Feb-2023 - Abbott announces u.S. And european approvals for new technologies to support effective treatment for abnormal heart rhythms
19-Dec-2022 - Abbott launches the world’s smallest implantable, rechargeable spinal cord stimulation system for chronic pain
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Financial Deep Dive
Financial Ratios -
Activity Ratios
Growth Ratios
Leverage Ratios
Liquidity Ratios
Market Ratios
Profitability Ratios
Research Methodology
Disclaimer
Contact Us



List of Figures

Figure 1: Abbott Laboratories- SWOT Analysis
Figure 2: Abbott Laboratories - PESTLE Analysis
Figure 3: Abbott Laboratories - Average Share Price Trend - Dec-2022 to Nov-2023
Figure 4: Abbott Laboratories - Profit and Loss Statement - 2019-2022
Figure 5: Abbott Laboratories - Balance Sheet - 2019-2022
Figure 6: Abbott Laboratories - Cash Flow Statement 2019-2022
Figure 7: Abbott Laboratories - Activity Ratio Charts
Figure 8: Abbott Laboratories - Growth Ratio Charts
Figure 9: Abbott Laboratories - Leverage Ratio Charts
Figure 10: Abbott Laboratories - Liquidity Ratio Charts
Figure 11: Abbott Laboratories - Profitability Ratio Charts
Figure 12: Competing Players - Boston Scientific Corporation- Key Financials
Figure 13: Competing Players - Johnson & Johnson- Key Financials
Figure 14: Competing Players - Sanofi- Key Financials
Figure 15: Competing Players - Stryker Corporation- Key Financials

List of Tables

Table 1: Abbott Laboratories - Company Facts
Table 2: Abbott Laboratories - Top Executives
Table 3: Abbott Laboratories - Top Executives Biographies
Table 4: Abbott Laboratories - Subsidiaries
Table 5: Abbott Laboratories - Products
Table 6: Abbott Laboratories - Historic Events
Table 7: Abbott Laboratories - Share Price Trend - Dec-2022 to Nov-2023
Table 8: Abbott Laboratories - Ratio Analysis - 2019-2022
Table 9: Abbott Laboratories - Competing Players